Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

Gastrointestinal disorder adverse event reports that record this term

Kind of term
MedDRA preferred term

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From January 2004 to June 2026, FDA received 87,050 adverse event reports that record the MedDRA preferred term Gastrointestinal disorder. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 8,535 reports in the 12 months to June 2026 and 8,166 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Data version

openFDA FAERS release of 1 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 124 drug pages with 500 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Drugs that the reports with the term Gastrointestinal disorder name as a suspect product, in order of name
DrugClassReports with this term
AbataceptSelective T cell costimulation modulator581
Acetaminophen3,666
Acetaminophen Hydrocodone Bitartrate607
Acetaminophen Oxycodone Hydrochloride1,625
ActemraInterleukin-6 receptor antagonist4,219
AdalimumabTumor necrosis factor blocker1,996
Aimovig691
Alendronate sodiumBisphosphonate1,848
Alendronate Sodium Cholecalciferol565
Alendronic Acid1,281
AlliIntestinal lipase inhibitor2,148
ApremilastPhosphodiesterase 4 inhibitor735
AprepitantSubstance P/Neurokinin-1 receptor antagonist555
AravaAntirheumatic agent3,269
AspirinNonsteroidal anti-inflammatory drug510
AzathioprinePurine antimetabolite1,000
Calcium carbonateBlood coagulation factor878
Calcium Glubionate761
CandesartanAngiotensin 2 receptor blocker655
CelebrexNonsteroidal anti-inflammatory drug1,393
CelecoxibNonsteroidal anti-inflammatory drug892
Certolizumab pegolTumor necrosis factor blocker841
CetirizineHistamine-1 receptor antagonist1,528
Cetirizine hydrochlorideHistamine-1 receptor antagonist1,912
Cetirizine hydrochloride, pseudoephedrine hydrochlorideHistamine-1 receptor antagonist1,224
Chloraprep986
Chlorhexidine2,087
Chlorhexidine gluconate1,321
Cholecalciferol669
CimziaTumor necrosis factor blocker3,679
CortisoneCorticosteroid935
Cortisone acetateCorticosteroid1,574
CosentyxInterleukin-17A antagonist2,645
CyclophosphamideAlkylating drug973
DesoximetasoneCorticosteroid2,687
DexamethasoneCorticosteroid760
DiclofenacNonsteroidal anti-inflammatory drug2,116
Diclofenac diethylamine752
Diclofenac potassiumNonsteroidal anti-inflammatory drug1,079
Diclofenac sodiumNonsteroidal anti-inflammatory drug2,497
DoxycyclineTetracycline-class drug585
DupixentInterleukin-4 receptor alpha antagonist787
EnbrelTumor necrosis factor blocker5,348
Erelzi2,007
ErgocalciferolProvitamin D2 compound913
EtanerceptTumor necrosis factor blocker553
Flumethasone Pivalate1,217
Folic acid2,905
FosamaxBisphosphonate2,675
GoldStandardized chemical allergen583
Gold Sodium Thiomalate604
GolimumabTumor necrosis factor blocker800
Humira6,445
HydrocortisoneCorticosteroid1,114
Hydrocortisone acetateCorticosteroid798
HydroxychloroquineAntimalarial2,722
Hydroxychloroquine sulfateAntimalarial2,412
IbuprofenNonsteroidal anti-inflammatory drug843
InfliximabTumor necrosis factor blocker2,127
Isopropyl alcoholStandardized chemical allergen962
KevzaraInterleukin-6 receptor antagonist1,082
LeflunomideAntirheumatic agent4,115
Lyrica813
MetforminBiguanide940
MethotrexateFolate analog metabolic inhibitor6,390
Methotrexate sodiumFolate analog metabolic inhibitor1,768
MethylprednisoloneCorticosteroid540
Methylprednisolone sodium succinateCorticosteroid592
Morphine sulfateOpioid agonist555
MounjaroGLP-1 receptor agonist957
Mycophenolate mofetilAntimetabolite immunosuppressant1,666
Myochrysine510
NaproxenNonsteroidal anti-inflammatory drug1,026
Naproxen sodiumNonsteroidal anti-inflammatory drug1,008
Novothyrox604
OfevKinase inhibitor694
OrenciaSelective T cell costimulation modulator4,160
OtezlaPhosphodiesterase 4 inhibitor2,410
OxycodoneOpioid agonist2,639
Oxycodone and acetaminophenOpioid agonist697
Oxycodone hydrochlorideOpioid agonist1,632
Oxycodone Terephthalate2,331
OxyContinOpioid agonist525
OzempicGLP-1 receptor agonist857
PantoprazoleProton pump inhibitor809
Pantoprazole sodiumProton pump inhibitor607
PercocetOpioid agonist566
Periogard2,065
Phenylephrine hydrochloridealpha-1 adrenergic agonist533
Phthalylsulfathiazole1,943
PlaquenilAntimalarial1,701
PrednisoloneCorticosteroid595
PrednisoneCorticosteroid4,231
Pregabalin559
Pseudoephedrine1,361
Pseudoephedrine hydrochloridealpha-Adrenergic agonist1,510
RamiprilAngiotensin converting enzyme inhibitor884
RemicadeTumor necrosis factor blocker3,180
RevlimidThalidomide analog1,764
RinvoqJanus kinase inhibitor706
RituxanCD20-directed cytolytic antibody832
RituximabCD20-directed cytolytic antibody3,970
SimponiTumor necrosis factor blocker3,343
SkyriziInterleukin-23 antagonist605
StelaraInterleukin-12 antagonist1,851
Sulfamethoxazole2,030
Sulfamethoxazole and trimethoprimDihydrofolate reductase inhibitor antibacterial1,099
Sulfamethoxazole, trimethoprimDihydrofolate reductase inhibitor antibacterial1,270
SulfasalazineAminosalicylate3,472
TacrolimusCalcineurin inhibitor immunosuppressant502
Tecfidera2,176
TocilizumabInterleukin-6 receptor antagonist862
TofacitinibJanus kinase inhibitor521
Tofacitinib citrateJanus kinase inhibitor644
TopicortCorticosteroid699
Topiramate539
Tramadol hydrochlorideOpioid agonist936
TrulicityGLP-1 receptor agonist697
TysabriIntegrin receptor antagonist548
UstekinumabInterleukin-12 antagonist534
VedolizumabIntegrin receptor antagonist533
Vitamin cVitamin C841
XeljanzJanus kinase inhibitor3,476
ZepboundGLP-1 receptor agonist634

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 46 pharmacologic classes with 1,000 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Pharmacologic classes of the drugs that the reports with the term Gastrointestinal disorder name, in order of name
ClassReports with this term
Alkylating drug1,281
alpha-Adrenergic agonist1,511
Aminosalicylate3,883
Angiotensin 2 receptor blocker2,299
Angiotensin converting enzyme inhibitor1,595
Anti-epileptic agent1,444
Antimalarial6,863
Antimetabolite immunosuppressant2,131
Antirheumatic agent7,384
Atypical antipsychotic1,584
Benzodiazepine1,009
Biguanide1,519
Bisphosphonate5,026
Blood coagulation factor1,369
Calcineurin inhibitor immunosuppressant1,007
CD20-directed cytolytic antibody5,368
Corticosteroid16,867
Dihydrofolate reductase inhibitor antibacterial2,568
Fluoroquinolone antibacterial1,196
Folate analog metabolic inhibitor8,288
GLP-1 receptor agonist4,023
Histamine-1 receptor antagonist5,561
HMG-CoA reductase inhibitor1,019
Integrin receptor antagonist1,502
Interleukin-12 antagonist2,385
Interleukin-17A antagonist3,106
Interleukin-6 receptor antagonist6,377
Intestinal lipase inhibitor2,167
Janus kinase inhibitor5,744
Kinase inhibitor4,590
Nonsteroidal anti-inflammatory drug12,291
Nucleoside metabolic inhibitor1,560
Opioid agonist9,873
Phosphodiesterase 4 inhibitor3,174
Platinum-based drug1,081
Prostacycline vasodilator1,192
Proton pump inhibitor3,415
Purine antimetabolite1,439
Selective T cell costimulation modulator4,741
Serotonin reuptake inhibitor1,000
Standardized chemical allergen1,545
Substance P/Neurokinin-1 receptor antagonist1,110
Tetracycline-class drug1,575
Thalidomide analog2,434
Tumor necrosis factor blocker22,585
Vitamin C1,103

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Gastrointestinal disorder, by month, five years to June 2026
01,0002,00020222023202420252026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Gastrointestinal disorder
AgeReportsShareShare as a bar
Under 22640.3%
2 to 118541%
12 to 179001%
18 to 4412,43814.3%
45 to 6418,11120.8%
65 to 749,43810.8%
75 and over6,5197.5%
Age not given38,52644.3%
Sex of the patient in the reports that record Gastrointestinal disorder
SexReportsShareShare as a bar
Female50,47058%
Male23,79127.3%
Unknown or not given12,78914.7%

Age and sex are as the report gives them. 61.4% of these reports give the United States as the country.

Terms near this one

Official pages

The site checked these addresses on . The links open in a new tab.

Cite this page

Reported Reactions. Gastrointestinal disorder: adverse event reports that record this term. https://reportedreactions.com/reaction/gastrointestinal-disorder/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 1 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Oct 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Gastrointestinal disorder mean in an adverse event report?

It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.

Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on .